ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 251190 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 251190; 2) Community: the network communities that were significantly associated with the response to NSC 251190; 3) Molecule: the relationships between components within communities and NSC 251190; 4) MDR: the compounds that were significantly associated with the NSC 251190.

NSC Compound Enrichment Correlation
NSC 683558 Camptothecin Derivative 0.0459335986102865 0.072402751
NSC 683608 Null 0.0459335986102865 0.14248162
NSC 684440 Null 0.0459335986102865 0.12442226
NSC 696257 2,3-Dihydro-1,2-syn-2-[S-(L)-cysteinylsulfoxide-]-brefeldin A 0.0459335986102865 -0.0010701639
NSC 716258 Null 0.0459335986102865 0.39401698
NSC 727285 6-(hydroxymethyl)-1,4-anthracenedione. 0.0459335986102865 0.33520211
NSC 730035 6-amino-5-(4-fluorobenzyl)-7-(1-methyl-1H-benzo[d]imidazol-2 -yl)-5H-pyrrolo[2,3-b]pyrazine-2,3-dicarbonitrile 0.0459335986102865 0.17894934
NSC 735334 Null 0.0459335986102865 0.33196992
NSC 343499 CI-921: amsacrine derivative 0.0462077035966078 -0.078012439
NSC 610457 Camptothecin Derivative 0.0462077035966078 0.13729383
Total:56  Current:48    [First] [Prev] [Next] [Last]